C. Rancoule

2.2k total citations
77 papers, 1.7k citations indexed

About

C. Rancoule is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, C. Rancoule has authored 77 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 25 papers in Oncology and 20 papers in Molecular Biology. Recurrent topics in C. Rancoule's work include Effects of Radiation Exposure (11 papers), Advanced Radiotherapy Techniques (10 papers) and Sphingolipid Metabolism and Signaling (8 papers). C. Rancoule is often cited by papers focused on Effects of Radiation Exposure (11 papers), Advanced Radiotherapy Techniques (10 papers) and Sphingolipid Metabolism and Signaling (8 papers). C. Rancoule collaborates with scholars based in France, China and Colombia. C. Rancoule's co-authors include Jean‐Baptiste Guy, Alexis Vallard, Nicolas Magné, Sophie Espenel, Philippe Valet, Jean Sébastien Saulnier‐Blache, Sandra Grès, Claire Rodriguez‐Lafrasse, Rodolphe Dusaulcy and Cyrus Chargari and has published in prestigious journals such as PLoS ONE, Diabetes and Scientific Reports.

In The Last Decade

C. Rancoule

71 papers receiving 1.6k citations

Peers

C. Rancoule

ONCOL

PRM

SURGE

EPIDE

Shinya Abe Japan

Takeo Tanaka Japan

Jiying Wang China

Dong Chen China

Ryo Takahashi Japan

Sinéad Toomey Ireland

Charles H. Fraga United States

Rongxue Wu United States

Gerasimos Tsourouflis Greece

Wei Xu China

Shinya Abe Japan

C. Rancoule

718 ×1.0

239 ×0.8

ONCOL

335 ×1.1

PRM

179 ×0.8

SURGE

176 ×0.9

EPIDE

Citations per year, relative to C. Rancoule C. Rancoule (= 1×) peers Shinya Abe

Countries citing papers authored by C. Rancoule

Since Specialization

Citations

This map shows the geographic impact of C. Rancoule's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Rancoule with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Rancoule more than expected).

Fields of papers citing papers by C. Rancoule

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Rancoule. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Rancoule. The network helps show where C. Rancoule may publish in the future.

Co-authorship network of co-authors of C. Rancoule

This figure shows the co-authorship network connecting the top 25 collaborators of C. Rancoule. A scholar is included among the top collaborators of C. Rancoule based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Rancoule. C. Rancoule is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vallard, Alexis, Sophie Espenel, C. Rancoule, et al.. (2019). Safety assessment of anticancer drugs in association with radiotherapy in metastatic malignant melanoma: a real-life report. Cancer Chemotherapy and Pharmacology. 83(5). 881–892. 5 indexed citations

Rivoirard, Romain, Julien Langrand-Escure, Mathieu Oriol, et al.. (2018). Evaluation of the quality of the reporting of phase II clinical trials in oncology: A systematic review. Critical Reviews in Oncology/Hematology. 125. 78–83. 1 indexed citations

Rancoule, C., Sophie Espenel, Jane‐Chloé Trone, et al.. (2018). Radiotherapy in triple-negative breast cancer: Current situation and upcoming strategies. Critical Reviews in Oncology/Hematology. 131. 96–101. 101 indexed citations

Méry, Benoîte, Sophie Espenel, Jean‐Baptiste Guy, et al.. (2018). Biological aspects of chondrosarcoma: Leaps and hurdles. Critical Reviews in Oncology/Hematology. 126. 32–36. 40 indexed citations

Espenel, Sophie, Alexis Vallard, Julien Langrand-Escure, et al.. (2017). Ototoxicité radio-induite et chimio-induite dans les cancers ORL : de la prévention primaire à la prévention tertiaire. Cancer/Radiothérapie. 21(1). 77–83. 5 indexed citations

Langrand-Escure, Julien, Romain Rivoirard, Mathieu Oriol, et al.. (2017). Quality of reporting in oncology phase II trials: A 5-year assessment through systematic review. PLoS ONE. 12(12). e0185536–e0185536. 8 indexed citations

Rancoule, C., Alexis Vallard, Julien Langrand-Escure, et al.. (2017). Immunothérapie : après le focus sur les voies de signalisation, l’activation d’un système. Bulletin du Cancer. 104(5). 462–475. 1 indexed citations

Vallard, Alexis, C. Rancoule, H. Le Floch, et al.. (2017). Prévention médicale et traitement des complications pulmonaires secondaires à la radiothérapie. Cancer/Radiothérapie. 21(5). 411–423. 11 indexed citations

Rivoirard, Romain, Alexis Vallard, Julien Langrand-Escure, et al.. (2016). Méthodologie des essais de phase I en radiothérapie : particularités. Cancer/Radiothérapie. 20(8). 833–836. 1 indexed citations

10.

Moncharmont, Coralie, et al.. (2016). Real-life efficacy of volumetric modulated arc therapy in head and neck squamous cell carcinoma. European Annals of Otorhinolaryngology Head and Neck Diseases. 134(3). 165–169. 7 indexed citations

11.

Chargari, Cyrus, Nicolas Magné, Jean‐Baptiste Guy, et al.. (2016). Optimize and refine therapeutic index in radiation therapy: Overview of a century. Cancer Treatment Reviews. 45. 58–67. 55 indexed citations

12.

Casteillo, François, Alexis Vallard, Sophie Espenel, et al.. (2016). Rhabdomyosarcomes d’origine gynécologique chez l’adulte : revue générale et principes de prise en charge. Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément. 45(8). 821–826.

13.

Espenel, Sophie, Alexis Vallard, C. Rancoule, et al.. (2016). Melanoma: Last call for radiotherapy. Critical Reviews in Oncology/Hematology. 110. 13–19. 47 indexed citations

14.

Rancoule, C., Alexis Vallard, Sophie Espenel, et al.. (2016). Immunotherapy in head and neck cancer: Harnessing profit on a system disruption. Oral Oncology. 62. 153–162. 8 indexed citations

15.

Rancoule, C., Nicolas Magné, Alexis Vallard, et al.. (2016). Nanoparticles in radiation oncology: From bench-side to bedside. Cancer Letters. 375(2). 256–262. 75 indexed citations

16.

Vallard, Alexis, Sophie Espenel, Jean‐Baptiste Guy, et al.. (2016). Targeting stem cells by radiation: From the biological angle to clinical aspects. World Journal of Stem Cells. 8(8). 243–243. 4 indexed citations

17.

Guy, Jean‐Baptiste, Alexis Vallard, Alexander T. Falk, et al.. (2015). Intensity-modulated salvage radiotherapy with simultaneous integrated boost for local recurrence of prostate carcinoma: a pilot study on the place of PET-choline for guiding target volume delineation. British Journal of Radiology. 89(1058). 20150579–20150579. 7 indexed citations

18.

Guy, Jean‐Baptiste, C. Rancoule, Benoîte Méry, et al.. (2015). Radiosensibilité et/ou résistance des cancers ORL : aspects biologiques. Bulletin du Cancer. 103(1). 41–47. 7 indexed citations

19.

Rancoule, C., Rodolphe Dusaulcy, Karine Tréguer, et al.. (2013). Involvement of autotaxin/lysophosphatidic acid signaling in obesity and impaired glucose homeostasis. Biochimie. 96. 140–143. 80 indexed citations

20.

Rancoule, C., Jean‐Philippe Pradère, Julien Gonzalez, et al.. (2011). Lysophosphatidic acid-1-receptor targeting agents for fibrosis. Expert Opinion on Investigational Drugs. 20(5). 657–667. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact